$37.92
Value $985M
HIPO and MS stock compared: price, dividend, valuation and results, from SEC filings.
$37.92
Value $985M
$185.57
Value $295B
Hippo (HIPO) has a market value of $985M and Morgan Stanley (MS) $295B. Over the last year, with dividends, HIPO moved +20.8% and MS +15.8%. The P/E is 30.8 for HIPO and 14.9 for MS. Dividend yield: HIPO none, MS 2.32%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
HIPO$985M
MS$295B
MS is 299 times HIPO
Revenue, 12 months
HIPO$543M
MS$80.2B
MS is 148 times HIPO
Net income, 12 months
HIPO$32M
MS$20.5B
MS is 639 times HIPO
Operating margin
HIPO–
MS–
ROIC
HIPO7.1%
MS4.4%
2.7 points apart
P/E
HIPO30.8
MS14.9
HIPO is 2.1 times MS
Dividend yield
HIPO0.0%
MS2.3%
2.3 points apart
5-year return
HIPO-61.2%
MS+116.8%
178.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
HIPO-61.2%
MS+116.8%
| Period | HIPOWith dividends | MSWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | +20.8%Price +20.8% | +15.8%Price +13.2% |
| 3 years since November 16, 2023 | +375.2%+68.1% a yearPrice +375.2% | +153.8%+36.4% a yearPrice +133.0% |
| 5 years since November 15, 2021 | -61.2%-17.3% a yearPrice -61.2% | +116.8%+16.7% a yearPrice +85.2% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
HIPOHippoMSMorgan Stanley
| Price | $37.92 | $185.57 |
|---|---|---|
| Market value | $985M | $295B |
| Enterprise value (EV) | $610M | – |
| P/E | 30.8 | 14.9 |
| P/E, 5-year median | – | 15.8 |
| P/B | 2.1 | 2.5 |
| EV/EBIT | 18.0 | – |
| Free cash flow yield | 12.9% | – |
| Revenue, 12 months | $543M | $80.2B |
|---|---|---|
| Net income, 12 months | $32M | $20.5B |
| Free cash flow, 12 months | $127M | – |
| Earnings per share, 12 months | $1.23 | $12.60 |
| Revenue growth, year on year | 25.9% | 14.4% |
| Revenue growth a year, past | +55.5%over 5 years | +7.7%over 5 years |
| EPS growth a year, past | – | +9.6%over 5 years |
| Gross margin | – | – |
|---|---|---|
| Operating margin | – | – |
| Net margin | 5.9% | 25.5% |
| ROIC | 7.1% | 4.4% |
| ROE | 7.1% | 18.0% |
| Cash | $375M | $244B |
|---|---|---|
| Total debt | $3.2M | $378B |
| Net debt / EBITDA | -6.9 | – |
| Interest cover | – | – |
| Dividend yield | – | 2.3% |
|---|---|---|
| Dividend per share, 12 months | – | $4.30 |
| Dividend growth a year, past | – | – |
| Buyback yield | 1.5% | 1.6% |
| Shareholder yield | 1.5% | 3.9% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Morgan Stanley ($295B) is about 299.2 times Hippo ($985M), at today's prices.
Since November 15, 2021, HIPO's price moved -61.2% and MS's +85.2%. With dividends: HIPO -61.2% (-17.3% a year), MS +116.8% (+16.7% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Hippo and 2.32% for Morgan Stanley. Over the last twelve months they paid – and $4.30 per share.
At today's price, the P/E is 30.8 for HIPO and 14.9 for MS. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 5.9% for Hippo and 25.5% for Morgan Stanley, and the operating margin – and –. Revenue was $543M and $80.2B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.